Zurn Elkay (ZWS) director acquires 643 shares at $46.67
Zurn Elkay Water Solutions (ZWS) reported an insider equity transaction by a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Zurn Elkay Water Solutions (ZWS) reported an insider equity transaction by a director. On 10/15/2025, the director acquired 643 shares of common stock at a price of $46.67.
Following the transaction, the director beneficially owned 116,097 shares, held directly. According to the footnote, the shares reflect payment of director fees in restricted stock units that vested immediately, with settlement deferred until six months after the director’s cessation of board service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 643 | $46.67 | $30K |
Footnotes (1)
- F1. Payment of director fees in restricted stock units, which vested immediately, but is not paid out until six months after the Reporting Person's cessation of service as a director.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ZWS disclose in this Form 4?
What was the nature of the ZWS director’s transaction?
What is the transaction date on the ZWS Form 4?
Is the ownership direct or indirect after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.